Mirum Pharmaceuticals, Inc. (MIRM)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
As of 11:46AM EDT. Market open.
| Previous close | 25.91 |
| Open | 25.86 |
| Bid | 25.27 x 100 |
| Ask | 25.37 x 100 |
| Day's range | 25.28 - 25.92 |
| 52-week range | 23.14 - 35.56 |
| Volume | |
| Avg. volume | 492,657 |
| Market cap | 1.193B |
| Beta (5Y monthly) | 1.14 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Halozyme Therapeutics (HALO) Earnings Expected to Grow: Should You Buy?
Halozyme Therapeutics (HALO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Zacks
Mirum Pharmaceuticals, Inc. (MIRM) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
Mirum Pharmaceuticals (MIRM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Zacks
Mirum Pharmaceuticals (MIRM) Down 12.5% Since Last Earnings Report: Can It Rebound?
Mirum Pharmaceuticals (MIRM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
© 2024 Yahoo. All rights reserved.